Zolpidem 5 & 10 mg Orodispersible tablet
Product Description
ATHENA PHARMACEUTIQUES S.A.S
-
FR
-
2022On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Specifications
ATHENA PHARMACEUTIQUES S.A.S
-
FR
-
2022On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from ATHENA PHARMACEUTIQUES S.A.S (14)
-
Product Meloxicam 7.5 mg & 15 mg Orodispersible tablet
Meloxicam appears to have better gastrointestinal tolerance than non-selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) thanks to its preferential inhibition of COX-2 vs. COX-1. The Orodispersible tablets enhance patient compliance, administration without water and accuracy of dosage -
Product Prednisolone 1mg & 5mg Orally Disintegrating Tablet
n Prednisolone is highly effective and signifi cantly more effective that Non-Steroidal Anti-Infl ammatory Drugs (NSAIDs) in rheumatoid arthritis and may be used intermittently1.n Prednisolone is the active metabolite of prednisone and prednisone’s effi cacy is related to the patient’s hepatic fu... -
Product Prednisolone 1mg & 5mg Orally Disintegrating Tablet
Prednisolone is highly effective and signifi cantly more effective that Non-Steroidal Anti-Infl ammatory Drugs (NSAIDs) in rheumatoid arthritis and may be used intermittently1.n Prednisolone is the active metabolite of prednisone and prednisone’s effi cacy is related to the patient’s hepatic func... -
Product Racecadotril 10 & 30 mg sache
n Racecadotril is a guideline-recommended treatment to alleviate symptoms of acute diarrhoea1, 2, 3. Safety profile is similar to that of placebo. Racecadotril inhibits the degradation of enkephalins, which in turn have potent antisecretory activity but only little effect on motility in the gut i... -
Product Secnidazole 2 mg sachet
Next-generation 5-nitroimidazole prodrug granted priority review by the FDA with longer half-life (17h) allowing for a once-daily dosing.n Secnidazole has similar activity against the range of microorganisms associated with bacterial vaginosis compared to metronidazole or tinidazole whilst sparin... -
Product Tramadol 37.5 mg + Paracetamol 325 mg
Fixed-combination of two well-known and established analgesics, devoid of the gastrointestinal, cardiovascular and renal adverse events associated with Non-Steroidal Anti-inflammatory Drugs (NSAIDs) responsible for 3.500-16.500 death per year in the USA1, 2.n Fixed-dose combination treatment redu... -
Product Bilastine 10 mg & 20 mg
1. Bilastine is a potent, effective antihistamine, without sedation, without cardiac toxicity, it has absence of metabolism and does not interact with cytochrome P4502.2. In experimental models, Bilastine has shown an excellent dose-dependent activity when administered by oral or intravenous rout... -
Product Domperidone 10 mg Orodispersible Tablet
Selective D2/D3 dopamine antagonist.n Combine prokinetic and anti-emetic activities on gastrointestinal tract making it an ideal agent for treating gastroparesis (postprandial fullness, nausea, vomiting and stomach fullness). Does not cross the blood-brain barrier minimizing CNS adverse events -
Product Donepezil 5 & 10 mg OroDispersible Tablet
Lesser behaviour deterioration vs. Galantamine14.n Superior Global Responder Rate vs. Galantamine14.n Lower risk of treatment withdrawals for any reason or because of an adverse event for Donepezil vs. Rivastigmine or Galantamine14 -
Product Esomeprazole 20 & 40 mg Enteric coated pellets in capsules
First single stereospecific S-isomer of omeprazole less prone to first-pass metabolism1.n Higher bioavailability than omeprazole2.n Superior acid control compared with all other Proton Pump Inhibitors (omeprazole, pantoprazole, lansoprazole & rabeprazole)3, 4, -
Product Etifoxine 50 mg Capsules
Anxiolytic effect equivalent to lorazepam, a higher responder rate, and a lower rate of rebound anxiety at treatment discontinuation (one week) in patients receiving etifoxine5. -
Product Fenofibrate 160 , 200 & 267 mg
Fenofibrate is a third generation fibric acid practically insoluble in water, making it challenging to consistently achieve therapeutic levels1, 2. Micronization technology dramatically improves the dissolution rate-limited gastrointestinal absorption.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance